Prof. Tom Eisenmann - "Why Startups Fail"

Sal's Investment Syndicate: Click to Join Harvard's Tom Eisenmann is the author of Why Startups Fail: A New Roadmap for Entrepreneurial Success. We discussed valuable lessons from the book and how they might apply to biotech startups. Highlights: Sal Daher Introduces Prof. Tom Eisenmann of the Harvard Business School, Author of Why Startups Fail Howard Stevenson's 400X Return Contrasting Brad Feld's Book with Prof. Tom Eisenmann's Book Sal Daher's Favorite Part of the Book: Failing "[failed] founders probably cycle through those. ...the Kubler Ross stages..." "...basically, half of failed founders come back and get back on the horse and do it again." Shutting Down the Failed Venture, Gracefully The Number One Killer of Startups: False Starts "...engineers are particularly vulnerable to this because they want to build." Sal Daher Discusses SQZ Biotech's False Start and Brilliant Pivot The Origin Story of Why Startups Fail "...the factories that actually make this stuff actually generate enough cash to invest in new apparel companies..." Silver Linings of the Pandemic Tom Eisenmann on Harvard's School of Engineering and the MS/MBA Program Tom Eisenmann on Tough Tech: Technical Uncertainty + Market Uncertainty Creating Supports for Life Science Academics to Become Founders Creative Destruction Labs Sal Daher's Focus on Biotech Angel Formation Software Startup Funding vs. Biotech Startup Funding Maybe Successful Angel-Backed Founders Such as Todd Zion and Armon Sharei Could be a Resource for Training Angels The Dynamics of Venture Capital in the Last Decade – Many New Shoots Tom Eisenmann's Parting Thoughts Sponsored by: Purdue University entrepreneurship, and Peter Fasse, patent attorney at Fish & Richardson Topics: biotech, management, co-founders, Mass Challenge, raising money, scholar, venture capital